中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial

文献类型:期刊论文

作者Lu, S.3; Jian, H.3; Zhang, Y.4; Song, Z.4; Zhao, Y.5; Wang, P.6; Jiang, L.3; Gong, Y.7; Zhou, J.8; Dong, X.9
刊名JOURNAL OF THORACIC ONCOLOGY
出版日期2022-09-01
卷号17
ISSN号1556-0864
关键词Non-small cell lung cancer KRAS G12C mutation Small molecular inhibitor
WOS研究方向Oncology ; Respiratory System
语种英语
出版者ELSEVIER SCIENCE INC
WOS记录号WOS:000858678100017
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/129929]  
专题中国科学院合肥物质科学研究院
作者单位1.Hunan Canc Hosp, Changsha, Peoples R China
2.Henan Prov Peoples Hosp, Zhengzhou, Peoples R China
3.Shanghai Jiao Tong Univ, Shanghai Lung Canc Ctr, Shanghai Chest Hosp, Shanghai, Peoples R China
4.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
5.Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China
6.Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China
7.Chongqing Univ, Chongqing Canc Hosp, Canc Hosp, Chongqing, Peoples R China
8.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
9.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Changsha, Peoples R China
10.Beijing Canc Hosp, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Lu, S.,Jian, H.,Zhang, Y.,et al. Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17.
APA Lu, S..,Jian, H..,Zhang, Y..,Song, Z..,Zhao, Y..,...&Wang, Y..(2022).Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial.JOURNAL OF THORACIC ONCOLOGY,17.
MLA Lu, S.,et al."Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial".JOURNAL OF THORACIC ONCOLOGY 17(2022).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。